Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $480,609 (100.0% shares, 0.0% debt)

Holdings (10)

— ABIOMED INC 38.8%

Value ($000) $186,441 Shares 1,450,000 Est. Cost $21.56 Unrealized —

— ENTELLUS MED INC 17.6%

Value ($000) $84,577 Shares 3,813,197 Est. Cost $21.90 Unrealized —

— REVANCE THERAPEUTICS INC 15.5%

Value ($000) $74,437 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— CORIUM INTL INC 11.0%

Value ($000) $52,659 Shares 9,353,304 Est. Cost $7.77 Unrealized —

AXGN AXOGEN INC 9.1%

Value ($000) $43,896 Shares 4,861,111 Est. Cost $4.01 Unrealized +102.9%

— ENDOLOGIX INC 4.8%

Value ($000) $22,855 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 1.8%

Value ($000) $8,766 Shares 1,170,370 Est. Cost $2.95 Unrealized +128.4%

ACUR ACURA PHARMACEUTICALS INC 0.7%

Value ($000) $3,130 Shares 1,956,397 Est. Cost $3.40 Unrealized -47.9%

LGND LIGAND PHARMACEUTICALS INC 0.5%

Value ($000) $2,400 Shares 32,893 Est. Cost $74.21 Unrealized -1.1%

— CATALYST BIOSCIENCES INC 0.3%

Value ($000) $1,448 Shares 1,179,352 Est. Cost $4.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	1,450,000	$186,441	38.8%	$21.56	—	COM	003654100
—	ENTELLUS MED INC	3,813,197	$84,577	17.6%	$21.90	—	COM	29363K105
—	REVANCE THERAPEUTICS INC	4,592,047	$74,437	15.5%	$31.50	—	COM	761330109
—	CORIUM INTL INC	9,353,304	$52,659	11.0%	$7.77	—	COM	21887L107
AXGN	AXOGEN INC	4,861,111	$43,896	9.1%	$4.01	+102.9%	COM	05463X106
—	ENDOLOGIX INC	1,257,468	$22,855	4.8%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$8,766	1.8%	$2.95	+128.4%	COM NEW	58468P206
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$3,130	0.7%	$3.40	-47.9%	COM PAR	00509L802
LGND	LIGAND PHARMACEUTICALS INC	32,893	$2,400	0.5%	$74.21	-1.1%	COM NEW	53220K504
—	CATALYST BIOSCIENCES INC	1,179,352	$1,448	0.3%	$4.80	—	COM	14888D109